Savings & More ™ The Patch Partnership Program is designed to help you: • Find out how you may be able to save on NEUPRO • Understand RLS • Get the most out of your doctor’s visits Sign up today at www.PatchPartnershipRLS.com INSIDE: Please see the enclosed Product Use Brochure and Prescribing Information for NEUPRO. .NEUPRORLS.comwww . e d i s n i O R UP E N r o f ed. USP-NR-0515-00006eserv All rights r on ati m or f n I g n i b i r c s e r P d n a e r u h c o r B A 30080. ©2015 UCB, Inc., Smyrna, G oup of Companies. of the UCB Gr e Ust c u d o r P , on ati m or f n I ademarks, e tr am™ ar ogr atient Savings PrP y t e t Saf n a t r o p m e I h e t e e s s a le P am™ and NEUPROogr ship Pr artner ch P at P ademark, and ed tr ert egis is a r® NEUPRO .estrictions, terms, and conditions apply*Eligibility r . y da e thr e i l r a e .NEUPROSavingsRLS.comat www t r a t r s n o e s r o , w n r u t e t r a h s t m o t p m y S s L d R n a *for as low as $10 a month for 12 months , s n o i t c a e e rt i in s k , s s e g r l u a u s nu , u g in t in a , f e t a r See how you may be able to get NEUPRO t r a e d h n e a r u s s e r d p o o l s in be s a e r c e r d s o e s a e r c in , s e i t i v i t c l a ma r o g n in r u p d e e l s g a inl l a , f e t fi l u s i b a t e m m u di o s t en di e r ng i he t o t s oni t ac e r c gi erl l a e er v e s g in d u l c s int c e f f e e d i s s u o i r e e s s au n c a O c R P U E N on i at m or f n I y et af S t n a t por m I . 8 8 0 1 - A D F - 0 0 8 - l 1l a r c h o c t a w d e m / v o g . a d f . w w t wi s i . V A D e F h o tt s g u r n d o i t p i r c s e r f p s o t c e f f e e d i e s v i t a g e t n r o p e o r d t e g a r u o c n e er u a o Y m co S. L R O R P U E N . w w w t a ™ m a r g ro P ip h s r e n t r a h P c t a e P h r t o p f n u g i d s n e a r n mo r a e L . y l p p s a n o i t i d n o d c n , a s m r e , ts n o i t c i r t s e y rt i l i b i g i l E * 4/8/14 6:53 AM 80407-2_760_39244_CoPayBckr_KLG.indd 1 030455-0314ATG-PRM-R 2014.y 28,ebruar–F 2014y 1,uareen Janocessed betw†Based on >5,000 claims pr ed.v eser GA 30080. All rights ryrna,., Sm Inc©2014 UCB, m o c . S L R s g n i v Sa O R P U E N . w w t w * a s h t n o 2 m r 1 o h ft n o 0 a m 1 $ oup of Companies. of the UCB Gr is a trademark,™ogramvings PrSa o Patient and the Neupred trademark,egister is a r®oNeupr3 6 2 0 1- 4 8- 5 5 8 1- . without notice y time ogram at an es the right to change or cancel this prveserUCB r . et expenseerms and Conditions.Tditional um $10 out-of-pockor ad.com fo.neupror at least a minimd or wwwesponsible fe rerse side of carveEligible patients ar*See rt a™margors Pgnivat Sneitao PrpueN s w a o s l r a o O f R P U E t N e o g le t b e a y b a u m o w y o e h e S -0263 -855-8411 e h l tla , cdra e ch e ttavitc o aT or the next 12 months*F call d, o activate this carT d Car vings atient SaP † ™ ma rg o r s Pgniva t Sneit a o Prpue N (80840)ISSUER: e h h tti h wtno a m0 1$ d aip er f f O s g n vi a S 50776476RxGRP: S T N E I T A LE PBI G LI E yalty Lo RxPCN: OF % 80 LY R A E N 610524RxBIN: .dra e ccnarusnn it aon ss iih. Tswae ltatd snl aareded fns aelum rargoro pt tnausrud pesnepsit dcudor. Pway ld betibihore psiwrehte orehr w, o)ocio RtreuP n e ilbaliavn aale Pcnarusnh Itlaet Hnemnrevoe Ghd tns amargore pcnatsissg aurn doitpircsere ptaty sng anidulcnis (margord pednuf etatr sl oareder falimiy sn, adiacide, M)t Drag Pnidulcnie (racider Medn, utrar pe olohn w, idesrubmiee rrt aahs tnoitpircserr pod filat vo N* : nsoitndio Cnd asmreT S L R y r a m i r p re ve e s . y time without noticegram at ano es the right to amend or terminate this prveserUCB r erms and Conditions.Tditional or ad.com fo.neuprd or wwwvings Caratient Sao P erse side of NeuprveSee r S.LRr o fOPRUEN isisTh omc. p hisr net r a P h c t a Pt as uni o J - o t - e t a r e d o n m f i e i l e m r o t p m y s . ™ m ar g or p Pihsr en tr a h Pcta ur P h ogu o hr n toitid n o ur co e ygan a m p le o h s tec uros e l rufple d hn , aslo o , tspi t tro p p e suviece n ra u co , ysgniv a s sedis e B e t le p m o r c o l f a i t n e t o n p e v o r P • n oi ptircs e r pru o y ng illin f he y wca m ra h r puo t ya d r a Csg ni v a t Snei at ro Ppu e N .tese rt mel he t tnes er P ngi s o d y l ai d - e c n O • * O PR U E f N s oht on 2 m t 1xe e nh r tof dluoy wehsh tit wsuI j n o i t a c i d e s m u uo n i t n o f c s o r u o 4 h 2 • h t n o 0 a m1 s $ w a o l s a y a P .evitce ae bp mley heTh gs.ee lre asehT . S L r R o O f R P U E s N s i i h T . s g e le r e a s e h T ome..e primary Restless Legs Syndreat moderate-to-severused to tr escription medicineotigotine transdermal system) is a pr (r®NEUPRO